Powder for suspension for Injection Triptorelin 3.75mg (Prostazar SR) Technical Specification:
Product Name: | Powder for suspension for Injection Triptorelin 3.75mg |
Brand Name: | Prostazar SR |
Strength: | 3.75mg, 11.25mg, 22.5mg |
Dosage Form: | Lyophilized Dry Powder for Injection |
Packing: | SINGLE USE VIAL |
Route of Administration: | For I.M. use only |
Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
Therapeutic use: | Anti-Cancer |
Indication: | Triptorelin is a hormone drug that you might have as a treatment for prostate cancer that is advanced (spread to other parts of your body) locally advanced with or without radiotherapy or surgery |
Storage: | Store the vials in the original carton between 2°C to 8°C (36° to 46° F). Protect from light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Powder for suspension for Injection Triptorelin 3.75mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Powder for suspension for Injection Triptorelin 3.75mg
Each sterile lyophilized vial contains:
Triptorelin Pamoate
Equivalent to Triptorelin.….…3.75mg
(Lyophilized powder for suspension for injection)
Excipients:
Anhydrous Citric Acid USP….q.s.
Mannitol USP……………………..q.s.
Water for Injection USP……..q.s.
THERAPEUTIC INDICATION:
Triptorelin is a hormone drug that you might have as a treatment for prostate cancer that is advanced (spread to other parts of your body) locally advanced with or without radiotherapy or surgery
PACKING:
- Powder for suspension for Injection Triptorelin 3.75mg – 1 Month
- Powder for suspension for Injection Triptorelin 11.25mg – 3 Month
- Powder for suspension for Injection Triptorelin 22.5mg – 6 Month
DIRECTION OF USE:
For Intramuscular use only.
Reconstitution: Must reconstitute with 2 ml sterile water for injection USP prior to administration and use the preparation immediately.
For further information refer package insert.
CAUTION & WARNING:
CAUTION: This injection should not be used if it contains visible particulate matter after reconstitution.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital only.
Opening instructions: Open the top and bottom flaps initially and then open the side flap.
TRANSPORT ONLY IN REFRIGERATION CHAIN.
INJECT INSTANTLY AFTER MIXING.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
Discard Unused portion.
Keep out of the reach of the children.
STORAGE & DOSAGE:
Storage: Store the vials in the original carton between 2°C to 8°C (36° to 46° F). Protect from light.
Dosage: As directed by an Oncologist.
GENERIC NAME OF THE MEDICINAL PRODUCT:
a) Powder for suspension for Injection Triptorelin 3.75mg
b) Powder for suspension for Injection Triptorelin 11.25mg
c) Powder for suspension for Injection Triptorelin 22.5mg
b) Powder for suspension for Injection Triptorelin 11.25mg
c) Powder for suspension for Injection Triptorelin 22.5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
a) Powder for suspension for Injection Triptorelin 3.75mg
Each sterile lyophilized vial contains:
Triptorelin Pamoate
Equivalent to Triptorelin.….…3.75mg
(Lyophilized powder for suspension for injection)
Excipients:
Anhydrous Citric Acid USP….q.s.
Mannitol USP……………………..q.s.
Water for Injection USP……..q.s.
b) Powder for suspension for Injection Triptorelin 11.25mg
Each sterile lyophilized vial contains:
Triptorelin Pamoate
Equivalent to Triptorelin.….…11.25mg
(Lyophilized powder for suspension for injection)
Excipients:
Anhydrous Citric Acid USP….q.s.
Mannitol USP……………………..q.s.
Water for Injection USP……..q.s.
c) Powder for suspension for Injection Triptorelin 22.5mg
Each sterile lyophilized vial contains:
Triptorelin Pamoate
Equivalent to Triptorelin.….…22.5mg
(Lyophilized powder for suspension for injection)
Excipients:
Anhydrous Citric Acid USP….q.s.
Mannitol USP……………………..q.s.
Water for Injection USP……..q.s.
Each sterile lyophilized vial contains:
Triptorelin Pamoate
Equivalent to Triptorelin.….…3.75mg
(Lyophilized powder for suspension for injection)
Excipients:
Anhydrous Citric Acid USP….q.s.
Mannitol USP……………………..q.s.
Water for Injection USP……..q.s.
b) Powder for suspension for Injection Triptorelin 11.25mg
Each sterile lyophilized vial contains:
Triptorelin Pamoate
Equivalent to Triptorelin.….…11.25mg
(Lyophilized powder for suspension for injection)
Excipients:
Anhydrous Citric Acid USP….q.s.
Mannitol USP……………………..q.s.
Water for Injection USP……..q.s.
c) Powder for suspension for Injection Triptorelin 22.5mg
Each sterile lyophilized vial contains:
Triptorelin Pamoate
Equivalent to Triptorelin.….…22.5mg
(Lyophilized powder for suspension for injection)
Excipients:
Anhydrous Citric Acid USP….q.s.
Mannitol USP……………………..q.s.
Water for Injection USP……..q.s.
THERAPEUTIC INDICATIONS:
Triptorelin is a hormone drug that you might have as a treatment for prostate cancer that is advanced (spread to other parts of your body) locally advanced with or without radiotherapy or surgery
PACKING:
1) Powder for suspension for Injection Triptorelin 3.75mg – 1 Month
2) Powder for suspension for Injection Triptorelin 11.25mg – 3 Month
3) Powder for suspension for Injection Triptorelin 22.5mg – 6 Month
2) Powder for suspension for Injection Triptorelin 11.25mg – 3 Month
3) Powder for suspension for Injection Triptorelin 22.5mg – 6 Month
DIRECTION OF USE:
For Intramuscular use only.
Reconstitution: Must reconstitute with 2 ml sterile water for injection USP prior to administration and use the preparation immediately.
For further information refer package insert.
Reconstitution: Must reconstitute with 2 ml sterile water for injection USP prior to administration and use the preparation immediately.
For further information refer package insert.
CAUTION AND WARNING:
CAUTION: This injection should not be used if it contains visible particulate matter after reconstitution.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital only.
Opening instructions: Open the top and bottom flaps initially and then open the side flap.
TRANSPORT ONLY IN REFRIGERATION CHAIN.
INJECT INSTANTLY AFTER MIXING.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
Discard Unused portion.
Keep out of the reach of the children.
WARNING: Cytotoxic Agent: To be sold by retail on the prescription of an Oncologist/ Cancer Hospital only.
Opening instructions: Open the top and bottom flaps initially and then open the side flap.
TRANSPORT ONLY IN REFRIGERATION CHAIN.
INJECT INSTANTLY AFTER MIXING.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE.
Discard Unused portion.
Keep out of the reach of the children.
STORAGE AND DOSAGE:
Storage: Store the vials in the original carton between 2°C to 8°C (36° to 46° F).
Protect from light.
Dosage: As directed by an Oncologist.
Protect from light.
Dosage: As directed by an Oncologist.